Peter Switzer speaks to Graham Kelly, the founder, CEO and managing director of Noxopharm (NOX).
Click the red button below to subscribe to our YouTube channel!
Peter Switzer is joined by the CEO of medical imaging company Imagion Biosystems (IBX), Robert Proulx.
Peter Switzer speaks to Kazia Therepeutics (KZA) CEO James Garner about the company's work to develop a new drug for cancer.
For an update on the company's progress in developing a portable brain scanner for detecting stroke, EMvision (ASX: EMV) CEO Dr Ron Weinberger joins Peter Switzer.
Peter Switzer is joined by Bryce Crocker, the CEO of mining and exploration company Jervois Mining (JRV).
Origin Energy CEO Frank Calabria sits down with Peter Switzer.
Peter Switzer speaks to the CEO of listed seafood company Clean Seas (CSS), David Head.
Peter Switzer talks to the CEO of dual-listed company Euro Manganese Inc (EMN), Marco Romero.
Peter Switzer sits down with the CEO of Galan Lithium (GLN), Juan Pablo Vargas de la Vega.
Peter Switzer sits down with Will Davidson, CEO of Powerwrap Limited's (ASX:PWL) Wealth Management Platform for Financial Advisers, Wealth Managers and Brokers.
Peter Switzer sits down with Lewis Utting, the CEO of wastewater treatment company SciDev (SDV).
Dr Ron Weinberger, CEO of EMvision (ASX:EMV), joins Peter Switzer.
Dr Graham Kelly shares his insights as the Executive Chairman of drug development biotech company Noxopharm.
Fill in the form below to subscribe to Switzer Daily and get our latest articles, videos and podcasts sent straight to your inbox